Results 281 to 290 of about 63,636 (348)
Comparison of inflammatory markers and microflora in cirrhotic patients with portal vein thrombosis: a retrospective study. [PDF]
Sun Y +6 more
europepmc +1 more source
This study developed a dynamic DNA nano‐antioxidant (DDN) for Galectin‐3 siRNA delivery, specifically targeting hepatic macrophages to suppress ROS‐driven fibrosis. DDN enhanced hepatic accumulation, restored NRF2 signaling, and attenuated oxidative stress, collagen deposition, and fibrotic progression in a CCl4‐induced cirrhosis model, demonstrating ...
Mengjia Peng +6 more
wiley +1 more source
Novel Hybrid Approach to Portal Vein Thrombectomy Immediately Prior to Orthotopic Liver Transplantation. [PDF]
Jou J, Pearson B, Haber Z, Ebaid S.
europepmc +1 more source
Lipid droplets (LDs) protect the heart against lipotoxicity in cardiac ischemia/reperfusion (I/R) injury; however, they are insufficient to prevent cardiomyocyte death. Seipin plays a central role in the insufficient formation of LDs, subsequent lipotoxicity, and myocardial injury during cardiac I/R injury.
Changyun Liu +13 more
wiley +1 more source
Coagulation Abnormalities in Liver Cirrhosis: Diagnostic and Therapeutic Approaches. [PDF]
Bozic D +7 more
europepmc +1 more source
Venous congestion and the geometry of Guyton. [PDF]
Kenny JS, Werner Moller P.
europepmc +1 more source
Utility of splenic transient elastography in assessing the presence of portal hypertension: A review. [PDF]
Abdulrasak M, Ahmed M, Hootak S.
europepmc +1 more source
Transient Extensive Portal Venous Gas in a Dialysis Patient. [PDF]
Martinez MJ, Murphy JJ, Halili FR.
europepmc +1 more source
Acute Variceal Bleeding 11 Years After a Successful Mesoatrial Shunt for Budd-Chiari Syndrome: A Case Report. [PDF]
Ali Elamin Babikir A +4 more
europepmc +1 more source

